COMP <GO>
SIBN vs JNJ // GROSS PROFIT MARGIN
SI-BONE Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: SIBN 3
— JNJ 7
▲ GROSS PROFIT MARGIN LEADER: SIBN
LAST: $22.41 (+2.66%) • MKT CAP: $1.00B
gross-margins
79.60%
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
gross-margins
67.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SIBN VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SIBN | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 79.60% | 67.90% | +11.70 | SIBN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -10.30% | 25.50% | -35.80 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.90% | 2.97% | -3.87 | JNJ | /fcf-yield <GO> |
| Operating Margin | -11.10% | 34.70% | -45.80 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -9.40% | 28.50% | -37.90 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 20.20% | 6.00% | +14.20 | SIBN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.73 | 5.59 | +3.14 | SIBN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.6 | 62.1 | -3.45 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.00B | $662.49B | -$661.49B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SIBN REV | JNJ REV | SIBN GROSS % | JNJ GROSS % | SIBN FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $200.9M | $94.19B | 79.6% | 67.9% | -$9.1M | $19.70B |
| FY 2024 | $167.2M | $88.82B | 79.0% | 69.1% | -$22.9M | $19.84B |
| FY 2023 | $138.9M | $85.16B | — | — | -$18.7M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SIBN // BETA —
JNJ // BETA 1.08